What is Freed?
Freed operates as an AI-powered medical scribe, engineered to alleviate the administrative burden on clinicians. The platform intelligently transcribes patient visits, subsequently extracting, summarizing, and structuring medically relevant information. This process mirrors the function of a human scribe but without the associated training requirements, delivering formatted notes and additional documentation directly into a clinician's preferred EHR system. By automating these crucial documentation tasks, Freed aims to improve clinician satisfaction and allow for greater focus on patient care.
How much funding has Freed raised?
Freed has raised a total of $30M across 1 funding round:
Series A
$30M
Series A (2025): $30M with participation from Sequoia Capital and Scale Venture Partners
Key Investors in Freed
Sequoia Capital
Sequoia Capital is a prominent venture capital firm with a long-term investment approach, known for backing early-stage to late-stage companies. Their expertise spans various sectors, and they actively partner with entrepreneurs to build market-leading businesses globally.
Scale Venture Partners
Scale Venture Partners is an early-stage venture capital firm that focuses on investing in founders building category-defining businesses, particularly in the AI space. They provide hands-on advisory services to support companies from initial growth to scalable operations.
What's next for Freed?
With this substantial enterprise-level funding, Freed is poised for accelerated growth and market expansion. The strategic investment suggests a focus on scaling operations, enhancing its AI capabilities, and potentially broadening its integration with a wider array of EHR systems. The company's trajectory indicates a move towards solidifying its position as a leader in the AI medical scribe market, further empowering healthcare providers by optimizing their documentation workflows and improving overall practice efficiency. Future developments will likely center on refining its core technology and expanding its user base within the healthcare sector.
See full Freed company page